U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. Specification of the Unique Facility Identifier (UFI) System for Drug Establishment
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

Specification of the Unique Facility Identifier (UFI) System for Drug Establishment November 2014

Download the Final Guidance Document Read the Federal Register Notice
Final
Docket Number:
FDA-2013-D-0984
Issued by:
Guidance Issuing Office
Center for Drug Evaluation and Research

This guidance specifies the unique facility identifier (UFI) system for registration of domestic and foreign drug establishments. This guidance is intended to address provisions set forth in section 510 of the Federal Food, Drug, and Cosmetic Act (FD&C Act) (21 U.S.C. 360), as amended by the Food and Drug Administration Safety and Innovation Act (FDASIA) (Public Law 112-144), regarding the specification of the UFI system.

Submit Comments

Submit Comments Online

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2013-D-0984.

 
Back to Top